These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10401760

  • 1. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts.
    Simonson MS, Herman WH, Robinson A, Schulak J, Hricik DE.
    Transplantation; 1999 Jun 27; 67(12):1542-7. PubMed ID: 10401760
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS, Robinson AV, Schulak JA, Hricik DE.
    Transplantation; 2002 Apr 15; 73(7):1054-9. PubMed ID: 11965031
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of endothelin converting enzyme-1 in host liver during chronic cardiac allograft rejection.
    Lattmann T, Ortmann J, Horber S, Shaw SG, Hein M, Barton M.
    Exp Biol Med (Maywood); 2006 Jun 15; 231(6):899-901. PubMed ID: 16741020
    [Abstract] [Full Text] [Related]

  • 4. Effects of pravastatin on chronic rejection of rat cardiac allografts.
    Maggard MA, Ke B, Wang T, Kaldas F, Seu P, Busuttil RW, Imagawa DK.
    Transplantation; 1998 Jan 27; 65(2):149-55. PubMed ID: 9458006
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.
    Watschinger B, Sayegh MH, Hancock WW, Russell ME.
    Am J Pathol; 1995 May 27; 146(5):1065-72. PubMed ID: 7747801
    [Abstract] [Full Text] [Related]

  • 6. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B, Kim KS, Buelow R, Sayegh MH, Hancock WW.
    Transplantation; 1997 Jul 15; 64(1):14-9. PubMed ID: 9233694
    [Abstract] [Full Text] [Related]

  • 7. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ.
    Transplantation; 1995 Jun 27; 59(12):1647-53. PubMed ID: 7604433
    [Abstract] [Full Text] [Related]

  • 8. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 9. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P.
    Transplantation; 1999 Sep 27; 68(6):739-46. PubMed ID: 10515373
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y, Liu Y, Yuan Z, Tian L, Dallman MJ, Thompson PW, Tam PK, Lamb JR.
    Transplantation; 2007 Jun 27; 83(12):1602-10. PubMed ID: 17589344
    [Abstract] [Full Text] [Related]

  • 12. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
    Bédard EL, Jiang J, Parry N, Wang H, Liu W, Garcia B, Kim P, Chakrabarti S, Buelow R, Zhong R.
    Transpl Int; 2005 Mar 27; 18(3):341-9. PubMed ID: 15730496
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S, Bayer J, Schaub M, Heidt MC, Grebe M, Tillmanns H, Stadlbauer TH.
    Transplant Proc; 2009 Mar 27; 41(6):2625-7. PubMed ID: 19715988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplantation; 1995 Oct 15; 60(7):729-33. PubMed ID: 7570985
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H, Wu J, Xu D, Luo H, Daloze PM.
    Transplantation; 1993 Sep 15; 56(3):661-6. PubMed ID: 8212164
    [Abstract] [Full Text] [Related]

  • 20. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J, Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR.
    Nephrol Dial Transplant; 2002 May 15; 17(5):780-7. PubMed ID: 11981063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.